Key facts
- It has raised $6.5M across 1 recorded rounds; the latest was Early Stage VC ($6.5M) in Mar 2020.
- Notable investors include The Dana Foundation, National Institutes of Neurological Disorders and Stroke, New York State.
- Hybernia Medical has filed 4 Form Ds with the SEC since 2020, most recently Mar 2024 ($4.8M sold to 18 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Hybernia Medical
Funding rounds
1 roundsAbout Hybernia Medical
Developer of a cooling catheter system intended to help in the treatment of acute organ ischemia. The company's system facilitates metabolic engineering of the ischemic tissue through controlled modulation of its thermal energy and delivers hypothermic protection to the organ in need, enabling medical service providers to apply it during endovascular stroke treatment.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2006
- Employees
- 4
- Website
- hyberniamedical.com/
- Ownership
- Privately Held (backing)
Hybernia Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hybernia Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hybernia Medical in its N-PORT filings yet. We sweep new filings monthly.